Loading...
Inflation Reduction Act And Biosimilars Will Undermine Pricing Power
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
43.9%7D
0.2%1Y
43.9%7D
0.2%You can edit this narrative until Sep 1 10:19 PM. Then, changes will post as Updates.
You can edit this narrative until Sep 1 10:19 PM. Then, changes will post as Updates.